Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 20/20 | 0.87 |
| ▸ | PLG | P00747 | 2/20 | 0.87 |
| ▸ | PROC | P04070 | 2/20 | 0.87 |
| ▸ | F2 | P00734 | 8/20 | 0.77 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL2325887 | 0.95 | F10 (0.88) | F10PLGPROCF2PRSS1 | |
| Trifluoroacetic Acid SCHEMBL2332372 | 0.93 | F10 (0.88) | F10PLGPROCF2PRSS1 | |
| Trifluoroacetic Acid SCHEMBL2329357 | 0.92 | F10 (0.88) | F10PLGPROCF2PRSS1 | |
| Trifluoroacetic Acid SCHEMBL2363805 | 0.92 | F10 (0.77) | F10PLGPROCF2PRSS1 | |
| Trifluoroacetic Acid SCHEMBL2334128 | 0.92 | F10 (0.73) | F10PLGPROCF2PRSS1 | |
| Trifluoroacetic Acid SCHEMBL2329113 | 0.92 | F10 (0.89) | F10PLGPROCF2PRSS1 | |
| Trifluoroacetic Acid SCHEMBL2328672 | 0.92 | F10 (0.89) | F10PLGPROCF2PRSS1 | |
| Trifluoroacetic Acid SCHEMBL2328637 | 0.92 | F10 (0.88) | F10PLGPROCF2PRSS1 | |
| Trifluoroacetic Acid SCHEMBL2331724 | 0.92 | F10 (0.88) | F10PLGPROCF2PRSS1 | |
| Trifluoroacetic Acid SCHEMBL2326536 | 0.91 | F10 (0.72) | F10PLGPROCF2PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0853618-B1 | SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL -AZAHETEROCYCLYLAMIDE COMPOUNDS | AVENTIS PHARMA INC (US) | 2011-08-17 | — | — | EP | disclosed |
| US-7897601-B2 | Cannabinoid receptor modulators | INTERVET, INC. (US) | 2011-03-01 | — | — | US | disclosed |
| US-7884080-B2 | Administering an azetidinone compound for treating a disorder of lipid metabolism, pain, diabetes, a vascular condition, demyelination or nonalcoholic fatty liver disease; T-type calcium channel blocking agent, an antagonist of TRPV1, an agonist of TRPV1, of GPR119, antagonist of NPCL1 | SCHERING PLOUGH CORPORATION (US) | 2011-02-08 | — | — | US | disclosed |